Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
28,495,649
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
55,657,631
-
Shares change
-
-5,068,921
-
Total reported value, excl. options
-
$19,725,177
-
Value change
-
-$1,788,149
-
Number of buys
-
7
-
Number of sells
-
22
-
Price
-
$0.3544
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q1 2023
As of 31 Mar 2023 Oncocyte Corporation - Common Shares, No Par Value (OCX) had 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,657,631 shares of stock of the company.
Largest 10 holders included BROADWOOD CAPITAL INC, PURA VIDA INVESTMENTS, LLC, AWM Investment Company, Inc., VANGUARD GROUP INC, Defender Capital, LLC., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, and Penbrook Management LLC.
This table shows 51 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.